Semaglutide manufacturers seem to be taking advantage of America’s health crises to indulge in anticompetitive behavior.

GOP leaders are racing to try to get the bill to the White House by July 4. The multi-trillion-dollar bill would unlock tax ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...